Trygg Pharma Overview
- Founded
-
2009
- Status
-
Out of Business
- Employees
-
23
- Latest Deal Type
-
Out of Business
- Financing Rounds
-
4
- Investments
-
2
Trygg Pharma General Information
Description
Operator of a pharmaceutical enterprise focused on developing omega-3 fatty acids. The company engages in biotechnological research and development, manufacturing and selling of marine-based omega-3 fatty acid concentrate to the nutritional supplements market.
Contact Information
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Primary Office
- Fjordalléen 16
- 0115 Oslo
- Norway
Trygg Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Trygg Pharma Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Trygg Pharma Investments (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000000 000 | 01-Jan-2018 | 000000000 | 0000 | Pharmaceuticals | |
| Epax | 01-Dec-2010 | Buyout/LBO | 000.00 | Pharmaceuticals | 00000 000 |
Trygg Pharma Exits (2)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 000000000 00000000 | 01-Jan-2018 | 000000000 | 0000 | Completed |
|
| Epax | 01-Dec-2010 | Buyout/LBO | 000.00 | Completed |
|